RheaVita

A continuous and controlled pharmaceutical freeze-drying technology for unit doses

2 January 2018 | By Jos Corver, Pieter-Jan Van Bockstal, Thomas De Beer

Among the list of over 300 FDA and EMA approved biopharmaceutical products, around 50% are freeze-dried – indicating that freeze-drying is the preferred way of stabilising biopharmaceutical drug products that are unstable in aqueous solution, despite the high cost and long processing time linked to this manufacturing technique.1,2